Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

631 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 631 results

Large-scale testing (Phase 3)Study completedNCT00211978
What this trial is testing

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

Who this might be right for
HyperphosphatemiaKidney Failure
Nabi Biopharmaceuticals 110
Large-scale testing (Phase 3)Study completedNCT00124098
What this trial is testing

An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease
Amgen
Early research (Phase 1)Study completedNCT06775834
What this trial is testing

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hypertrophic Cardiomyopathy
Shandong Suncadia Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT02135276
What this trial is testing

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

Who this might be right for
End Stage Renal Disease
Tetraphase Pharmaceuticals, Inc 12
Post-approval studies (Phase 4)Ended earlyNCT00793182
What this trial is testing

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography

Who this might be right for
Renal Impairment
Guerbet 6
Large-scale testing (Phase 3)Study completedNCT00364260
What this trial is testing

A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.

Who this might be right for
AnemiaKidney FailureLeft Ventricular Hypertrophy
Janssen-Ortho Inc., Canada 172
Early research (Phase 1)Study completedNCT02508506
What this trial is testing

Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Alkermes, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT05018416
What this trial is testing

Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Who this might be right for
Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus
Prokidney 53
Testing effectiveness (Phase 2)Study completedNCT00721734
What this trial is testing

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Who this might be right for
Multiple MyelomaRenal Insufficiency
Amgen 50
Early research (Phase 1)Study completedNCT01875523
What this trial is testing

PK of Serelaxin in Severe Renal Impairment and ESRD

Who this might be right for
Renal Failure, ChronicEnd-Stage Renal Disease
Novartis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Early research (Phase 1)Study completedNCT01462136
What this trial is testing

PK Study of ACHN-490 Injection in Renally Impaired Subjects

Who this might be right for
Renal Insufficiency
Achaogen, Inc. 24
Early research (Phase 1)Study completedNCT01923857
What this trial is testing

Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 26
Early research (Phase 1)Not Yet RecruitingNCT07322016
What this trial is testing

HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Who this might be right for
Hyperlipidemias
Shandong Suncadia Medicine Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT01977573
What this trial is testing

Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Who this might be right for
Anaemia
GlaxoSmithKline 252
Large-scale testing (Phase 3)Study completedNCT02268994
What this trial is testing

KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

Who this might be right for
Anemia of Chronic Kidney Disease
Keryx Biopharmaceuticals 234
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Early research (Phase 1)Study completedNCT02007941
What this trial is testing

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

Who this might be right for
Renal ImpairmentHealthy
Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT01737866
What this trial is testing

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

Who this might be right for
Heart Failure
Cytokinetics 13
Testing effectiveness (Phase 2)Ended earlyNCT00381602
What this trial is testing

A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis

Who this might be right for
End Stage Renal Disease
QLT Inc. 3
Load More Results